[Consensus document on spasticity in patients with multiple sclerosis. Grupo de Enfermedades Desmielinizantes de la Sociedad Española de Neurología].

Oreja-Guevara C, Montalban X, de Andrés C, Casanova-Estruch B, Muñoz-García D, García I, Fernández Ó; Grupo de Enfermedades Desmielinizantes de la Sociedad Española de Neurología..

Rev Neurol. 2013 Oct 16;57(8):359-73. Spanish.

A single trial of transcutaneous electrical nerve stimulation (TENS) improves spasticity and balance in patients with chronic stroke.

Cho HY, In TS, Cho KH, Song CH.

Tohoku J Exp Med. 2013;229(3):187-93.

Preliminary results of ON/OFF detection using an integrated system for Parkinson's disease monitoring.

Pastorino M, Cancela J, Arredondo MT, Pastor-Sanz L, Contardi S, Valzania F.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:941-4. doi: 10.1109/EMBC.2013.6609657.

An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs).

Prakash BD, Esuvaranathan K, Ho PC, Pasikanti KK, Chan EC, Yap CW.

Analyst. 2013 May 21;138(10):2883-9. doi: 10.1039/c3an00048f.

Genetics in dystonia: an update.

Fuchs T, Ozelius LJ.

Curr Neurol Neurosci Rep. 2013 Dec;13(12):410. doi: 10.1007/s11910-013-0410-z. Review.

Quantitative profiling and identification of differentially expressed plasma proteins in Friedreich's ataxia.

Swarup V, Srivastava AK, Padma MV, Rajeswari MR.

J Neurosci Res. 2013 Nov;91(11):1483-91. doi: 10.1002/jnr.23262.

The Enemy within: Propagation of Aberrant Corticostriatal Learning to Cortical Function in Parkinson's Disease.

Beeler JA, Petzinger G, Jakowec MW.

Front Neurol. 2013 Sep 12;4:134. doi: 10.3389/fneur.2013.00134. Review.

What is measured with verbal fluency tests in Parkinson's disease patients at different stages of the disease?

Koerts J, Meijer HA, Colman KS, Tucha L, Lange KW, Tucha O.

J Neural Transm (Vienna). 2013 Mar;120(3):403-11. doi: 10.1007/s00702-012-0885-9.

Parkinson's and Alzheimer's diseases in Costa Rica: a feasibility study toward a national screening program.

Wesseling C, Román N, Quirós I, Páez L, García V, Mora AM, Juncos JL, Steenland KN.

Glob Health Action. 2013 Dec 27;6:23061. doi: 10.3402/gha.v6i0.23061.

Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.

Allen R, Oertel W, Walters A, Benes H, Schollmayer E, Grieger F, Moran K, Kohnen R.

Sleep Med. 2013 Dec;14(12):1375-80. doi: 10.1016/j.sleep.2013.09.008.

Tremor associated with focal and segmental dystonia.

Rudzińska M, Krawczyk M, Wójcik-Pędziwiatr M, Szczudlik A, Wasielewska A.

Neurol Neurochir Pol. 2013 May-Jun;47(3):223-31.

Origin of the spinocerebellar ataxia type 7 gene mutation in Mexican population.

Magaña JJ, Gómez R, Maldonado-Rodríguez M, Velázquez-Pérez L, Tapia-Guerrero YS, Cortés H, Leyva-García N, Hernández-Hernández O, Cisneros B.

Cerebellum. 2013 Dec;12(6):902-5. doi: 10.1007/s12311-013-0505-8.

Lack of association between the LRRK2 A419V variant and Asian Parkinson's disease.

Gopalai AA, Lim SY, Aziz ZA, Lim SK, Tan LP, Chong YB, Tan CT, Puvanarajah S, Viswanathan S, Kuppusamy R, Tan AH, Lim TT, Eow GB, Norlinah MI, Li HH, Zhao Y, Ahmad-Annuar A.

Ann Acad Med Singapore. 2013 May;42(5):237-40.

Senescence marker protein 30 deficiency increases Parkinson's pathology by impairing astrocyte activation.

Kim HS, Son TG, Park HR, Lee Y, Jung Y, Ishigami A, Lee J.

Neurobiol Aging. 2013 Apr;34(4):1177-83. doi: 10.1016/j.neurobiolaging.2012.10.008.

Structured interviews and ancillary" restless legs syndrome."

Sharon D.

Sleep Med. 2013 Jun;14(6):473-4. doi: 10.1016/j.sleep.2013.03.001. No abstract available.